novoGI is a biotechnology and healthcare startup that was founded in 1996. The company is focused on providing an expanding range of solutions for GI disease management through a globally branded, high quality, and market-driven approach. It has its US headquarters in Atlanta, Georgia, research, development, and manufacturing facilities in Netanya, Israel, and its European headquarters near Paris, France. The last recorded investment for novoGI was an impressive $18.50M Series F investment on 11 August 2009. This investment came from a group of prominent investors including Forbion, Alice Ventures, Cipio Partners, SCP Vitalife Partners, Israel Healthcare Ventures, and Evergreen Venture Partners.
By establishing a strong presence in both the United States and Europe, novoGI has positioned itself strategically for growth and innovation in the biotechnology and healthcare industries. The significant Series F investment in 2009 indicates a high level of confidence from established venture capital firms, affirming novoGI's potential for long-term success in the market. The company's focus on GI disease management aligns with the growing demand for innovative healthcare solutions, making it an attractive opportunity for venture capital firms seeking promising investments in the healthcare sector. As novoGI continues to expand its range of solutions and leverage its global presence, it presents an exciting prospect for potential investors looking to contribute to the advancement of healthcare technologies. With a track record of successful investments and a strong foundation, novoGI stands poised for continued growth and impact in the biotechnology and healthcare landscape.
novoGI
Founded 1996
Atlanta, United States
7 employees
Series F
Total: $18.50M
Biotechnology, Health Care +1
Atlanta, United States
7 employees
Series F
Total: $18.50M
Biotechnology, Health Care +1
General Information
Company Name
novoGI
Founded Year
1996
Location
Atlanta, United States
Atlanta, United States
Employees
7
Industries
Biotechnology, Health Care, Medical Devices
Funding Stage
Series F
BounceWatch is an independent company data service, not affiliated with novoGI. To contact novoGI, visit novogi.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About novoGI
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series F | $18.50M | 6 |
|
11 Aug 2009 |
novoGI Alternatives & Competitors
View All Alternatives
novoGI vs
GENFIT
France
Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical...
Post-IPO Equity
201 employees
Biopharma, Biotechnology
novoGI vs
Lab21 Ltd.
United Kingdom
Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing per...
Venture round
12 employees
Biotechnology, Health Care
novoGI vs
The Care Continues...
9205 employees
Biotechnology, Health Care
FAQ About novoGI
novoGI™ is focused on providing an expanding range of solutions for GI disease management through a globally branded, high quality, market driven company. The US headquarters are in Atlanta, Georgia; research, development and manufacturing facilities in Netanya, Israel; and its European headquarters...
novoGI was founded in 1996.
novoGI is headquartered in Atlanta, United States.
novoGI operates in Biotechnology, Health Care and Medical Devices.
novoGI has approximately 7 employees.
novoGI has completed 1 funding round, raising a total of $18.50M. The latest funding stage is Series F.
Top alternatives and competitors to novoGI include GENFIT, Lab21 Ltd., Cadila Pharmaceuticals Limited, Hanger, Inc., Amicus Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
novoGI and GENFIT are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for novoGI, https://bouncewatch.com/company/novogi, updated 12 September 2024. When citing, please name BounceWatch and link this page.
